Literature DB >> 9502827

Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.

S R Sesack1, V A Hawrylak, C Matus, M A Guido, A I Levey.   

Abstract

The dopamine transporter (DAT) critically regulates the duration of the cellular actions of dopamine and the extent to which dopamine diffuses in the extracellular space. We sought to determine whether the reportedly greater diffusion of dopamine in the rat prefrontal cortex (PFC) as compared with the striatum is associated with a more restricted axonal distribution of the cortical DAT protein. By light microscopy, avidin-biotin-peroxidase immunostaining for DAT was visualized in fibers that were densely distributed within the dorsolateral striatum and the superficial layers of the dorsal anterior cingulate cortex. In contrast, DAT-labeled axons were distributed only sparsely to the deep layers of the prelimbic cortex. By electron microscopy, DAT-immunoreactive profiles in the striatum and cingulate cortex included both varicose and intervaricose segments of axons. However, DAT-labeled processes in the prelimbic cortex were almost exclusively intervaricose axon segments. Immunolabeling for tyrosine hydroxylase in adjacent sections of the prelimbic cortex was localized to both varicosities and intervaricose segments of axons. These qualitative observations were supported by a quantitative assessment in which the diameter of immunoreactive profiles was used as a relative measure of whether varicose or intervaricose axon segments were labeled. These results suggest that considerable extracellular diffusion of dopamine in the prelimbic PFC may result, at least in part, from a paucity of DAT content in mesocortical dopamine axons, as well as a distribution of the DAT protein at a distance from synaptic release sites. The results further suggest that different populations of dopamine neurons selectively target the DAT to different subcellular locations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502827      PMCID: PMC6793120     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  75 in total

1.  Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.

Authors:  E Carboni; G L Tanda; R Frau; G Di Chiara
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

2.  Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical level.

Authors:  C G Van Eden; E M Hoorneman; R M Buijs; M A Matthijssen; M Geffard; H B Uylings
Journal:  Neuroscience       Date:  1987-09       Impact factor: 3.590

3.  5-hydroxydopamine-labeled dopaminergic axons: three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum.

Authors:  P M Groves; J C Linder; S J Young
Journal:  Neuroscience       Date:  1994-02       Impact factor: 3.590

4.  Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain.

Authors:  C Bergson; L Mrzljak; J F Smiley; M Pappy; R Levenson; P S Goldman-Rakic
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167

5.  Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax.

Authors:  R A Huff; R A Vaughan; M J Kuhar; G R Uhl
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

6.  Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase.

Authors:  P Gaspar; B Berger; A Febvret; A Vigny; J P Henry
Journal:  J Comp Neurol       Date:  1989-01-08       Impact factor: 3.215

Review 7.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates.

Authors:  B Berger; P Gaspar; C Verney
Journal:  Trends Neurosci       Date:  1991-01       Impact factor: 13.837

8.  Ultrastructural immunocytochemical localization of neurotensin and the dopamine D2 receptor in the rat nucleus accumbens.

Authors:  K T Delle Donne; S R Sesack; V M Pickel
Journal:  J Comp Neurol       Date:  1996-08-05       Impact factor: 3.215

9.  Developmentally regulated glycosylation of dopamine transporter.

Authors:  A P Patel; C Cerruti; R A Vaughan; M J Kuhar
Journal:  Brain Res Dev Brain Res       Date:  1994-11-18

10.  Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.

Authors:  S N Haber; H Ryoo; C Cox; W Lu
Journal:  J Comp Neurol       Date:  1995-11-20       Impact factor: 3.215

View more
  203 in total

Review 1.  Dopamine tunes prefrontal outputs to orchestrate aversive processing.

Authors:  Caitlin M Vander Weele; Cody A Siciliano; Kay M Tye
Journal:  Brain Res       Date:  2018-12-01       Impact factor: 3.252

2.  Connecting the dots of the cerebro-cerebellar role in cognitive function: neuronal pathways for cerebellar modulation of dopamine release in the prefrontal cortex.

Authors:  Tiffany D Rogers; Price E Dickson; Detlef H Heck; Dan Goldowitz; Guy Mittleman; Charles D Blaha
Journal:  Synapse       Date:  2011-06-17       Impact factor: 2.562

3.  Firing patterns of maternal rat prelimbic neurons during spontaneous contact with pups.

Authors:  Marcelo Febo
Journal:  Brain Res Bull       Date:  2012-05-27       Impact factor: 4.077

4.  No significant association between Catechol-O-methyl transferase (COMT) -287A/G gene polymorphism and Tourette's syndrome in family-based association study in Chinese Han population.

Authors:  Shiguo Liu; Mingji Yi; Fengguang Qi; Yuping Sun; Fengyuan Che; Xu Ma
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10-19       Impact factor: 4.785

5.  Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.

Authors:  Alessandro Bertolino; Leonardo Fazio; Annabella Di Giorgio; Giuseppe Blasi; Raffaella Romano; Paolo Taurisano; Grazia Caforio; Lorenzo Sinibaldi; Gianluca Ursini; Teresa Popolizio; Emanuele Tirotta; Audrey Papp; Bruno Dallapiccola; Emiliana Borrelli; Wolfgang Sadee
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

Review 6.  The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex.

Authors:  Robert C Spencer; David M Devilbiss; Craig W Berridge
Journal:  Biol Psychiatry       Date:  2014-09-28       Impact factor: 13.382

7.  Methylphenidate and atomoxetine enhance sensory-evoked neuronal activity in the visual thalamus of male rats.

Authors:  Rachel L Navarra; Brian D Clark; Gerard A Zitnik; Barry D Waterhouse
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

8.  The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion.

Authors:  J Smythies
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

9.  Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine.

Authors:  Ronald Kuczenski; David S Segal
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

10.  DAT by perceived MC interaction on human prefrontal activity and connectivity during emotion processing.

Authors:  Paolo Taurisano; Giuseppe Blasi; Raffaella Romano; Fabio Sambataro; Leonardo Fazio; Barbara Gelao; Gianluca Ursini; Luciana Lo Bianco; Annabella Di Giorgio; Francesca Ferrante; Apostolos Papazacharias; Annamaria Porcelli; Lorenzo Sinibaldi; Teresa Popolizio; Alessandro Bertolino
Journal:  Soc Cogn Affect Neurosci       Date:  2012-07-27       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.